Market Analysis and Insights: Global Classical Swine Fever Vaccines Market
It is a type of vaccine for classical swine fever. Classical swine fever (CSF), also known as hog cholera, is a contagious viral disease of pigs, including wild boar. The causative virus is a member of the genus Pestivirus of the family Flaviviridae, and is closely related to the viruses of bovine viral diarrhoea and border disease. There is only one serotype of CSF virus (CSFV).
Due to the COVID-19 pandemic, the global Classical Swine Fever Vaccines market size is estimated to be worth US$ 188.6 million in 2022 and is forecast to a readjusted size of US$ 260.1 million by 2028 with a CAGR of 5.5% during the review period. Fully considering the economic change by this health crisis, Tissue Culture Origin accounting for % of the Classical Swine Fever Vaccines global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Government Tender segment is altered to an % CAGR throughout this forecast period.
The global classical swine fever vaccine market is dominated by Winsun, Merial and CAHIC, with the top three manufacturers accounting for about 60% of the market share. Asia Pacific is the largest market for classical swine fever vaccines, with a market share of about 50%, followed by Europe with a market share of about 25%. Tissue Culture Origin is the main type, with a share about 60%. Market Sales is the main application, which holds a share about 95%.
Market Segments
The authors of this research report have explored the key segments: Type and Application. The report offers an in-depth breakdown of type and application segments and their sub-segments. The lucrativeness and growth potential have been looked into by the industry experts in this report. This section of the report also provides sales and revenue forecast data by type and application segments based on sales, price, and revenue for the period 2017-2028. The specialists, to broaden the understanding of the users, have done value chain and raw material analysis in this section.
Segment by Source
Tissue Culture Origin
Cell Line Origin
Segment by Sales Channel
Government Tender
Market Sales
Consequence of Covid-19 Pandemic
The authors of this study have enlightened the readers on the rise and effect of the Covid-19 outbreak on the development. They have investigated the changes brought about in the demand/supply side, consumption, supply chain, and sales/manufacturing. The readers will get familiar with the measures that have helped the key players to bring the Classical Swine Fever Vaccines market back to the pre-covid levels.
Trends & Prospects
In this segment of the report, the specialists have delved into the key growth opportunities that are likely to emerge. This will aid the key players to simplify complex issues related to business and frame future strategies to compete in this competitive environment. This section will certainly assist the players to boldly position their business.
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Competitive Outlook
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and share analysis of the prominent players are also provided in this section. They have also provided reliable sales and revenue data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
WINSUN
Merial
CAHIC
Chopper Biology
MSD Animal Health (Merck)
ChengDu Tecbond
Ceva
Harbin Veterinary Research Institute
Qilu Animal Health Products Factory
Ringpu Biology
DHN
CAVAC
Komipharm
Agrovet
Bioveta
Jinyu Bio-Technology
Institutul Pasteur
MVP
Tecon
1 Study Coverage
1.1 Classical Swine Fever Vaccines Product Introduction
1.2 Market by Source
1.2.1 Global Classical Swine Fever Vaccines Market Size Growth Rate by Source, 2017 VS 2021 VS 2028
1.2.2 Tissue Culture Origin
1.2.3 Cell Line Origin
1.3 Market by Sales Channel
1.3.1 Global Classical Swine Fever Vaccines Market Size Growth Rate by Sales Channel, 2017 VS 2021 VS 2028
1.3.2 Government Tender
1.3.3 Market Sales
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Classical Swine Fever Vaccines Sales Estimates and Forecasts 2017-2028
2.2 Global Classical Swine Fever Vaccines Revenue Estimates and Forecasts 2017-2028
2.3 Global Classical Swine Fever Vaccines Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Classical Swine Fever Vaccines Sales by Region
2.4.1 Global Classical Swine Fever Vaccines Sales by Region (2017-2022)
2.4.2 Global Sales Classical Swine Fever Vaccines by Region (2023-2028)
2.5 Global Classical Swine Fever Vaccines Revenue by Region
2.5.1 Global Classical Swine Fever Vaccines Revenue by Region (2017-2022)
2.5.2 Global Classical Swine Fever Vaccines Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Classical Swine Fever Vaccines Sales by Manufacturers
3.1.1 Global Top Classical Swine Fever Vaccines Manufacturers by Sales (2017-2022)
3.1.2 Global Classical Swine Fever Vaccines Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Classical Swine Fever Vaccines in 2021
3.2 Global Classical Swine Fever Vaccines Revenue by Manufacturers
3.2.1 Global Classical Swine Fever Vaccines Revenue by Manufacturers (2017-2022)
3.2.2 Global Classical Swine Fever Vaccines Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Classical Swine Fever Vaccines Revenue in 2021
3.3 Global Classical Swine Fever Vaccines Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Classical Swine Fever Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Classical Swine Fever Vaccines Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Source
4.1 Global Classical Swine Fever Vaccines Sales by Source
4.1.1 Global Classical Swine Fever Vaccines Historical Sales by Source (2017-2022)
4.1.2 Global Classical Swine Fever Vaccines Forecasted Sales by Source (2023-2028)
4.1.3 Global Classical Swine Fever Vaccines Sales Market Share by Source (2017-2028)
4.2 Global Classical Swine Fever Vaccines Revenue by Source
4.2.1 Global Classical Swine Fever Vaccines Historical Revenue by Source (2017-2022)
4.2.2 Global Classical Swine Fever Vaccines Forecasted Revenue by Source (2023-2028)
4.2.3 Global Classical Swine Fever Vaccines Revenue Market Share by Source (2017-2028)
4.3 Global Classical Swine Fever Vaccines Price by Source
4.3.1 Global Classical Swine Fever Vaccines Price by Source (2017-2022)
4.3.2 Global Classical Swine Fever Vaccines Price Forecast by Source (2023-2028)
5 Market Size by Sales Channel
5.1 Global Classical Swine Fever Vaccines Sales by Sales Channel
5.1.1 Global Classical Swine Fever Vaccines Historical Sales by Sales Channel (2017-2022)
5.1.2 Global Classical Swine Fever Vaccines Forecasted Sales by Sales Channel (2023-2028)
5.1.3 Global Classical Swine Fever Vaccines Sales Market Share by Sales Channel (2017-2028)
5.2 Global Classical Swine Fever Vaccines Revenue by Sales Channel
5.2.1 Global Classical Swine Fever Vaccines Historical Revenue by Sales Channel (2017-2022)
5.2.2 Global Classical Swine Fever Vaccines Forecasted Revenue by Sales Channel (2023-2028)
5.2.3 Global Classical Swine Fever Vaccines Revenue Market Share by Sales Channel (2017-2028)
5.3 Global Classical Swine Fever Vaccines Price by Sales Channel
5.3.1 Global Classical Swine Fever Vaccines Price by Sales Channel (2017-2022)
5.3.2 Global Classical Swine Fever Vaccines Price Forecast by Sales Channel (2023-2028)
6 North America
6.1 North America Classical Swine Fever Vaccines Market Size by Source
6.1.1 North America Classical Swine Fever Vaccines Sales by Source (2017-2028)
6.1.2 North America Classical Swine Fever Vaccines Revenue by Source (2017-2028)
6.2 North America Classical Swine Fever Vaccines Market Size by Sales Channel
6.2.1 North America Classical Swine Fever Vaccines Sales by Sales Channel (2017-2028)
6.2.2 North America Classical Swine Fever Vaccines Revenue by Sales Channel (2017-2028)
6.3 North America Classical Swine Fever Vaccines Market Size by Country
6.3.1 North America Classical Swine Fever Vaccines Sales by Country (2017-2028)
6.3.2 North America Classical Swine Fever Vaccines Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Classical Swine Fever Vaccines Market Size by Source
7.1.1 Europe Classical Swine Fever Vaccines Sales by Source (2017-2028)
7.1.2 Europe Classical Swine Fever Vaccines Revenue by Source (2017-2028)
7.2 Europe Classical Swine Fever Vaccines Market Size by Sales Channel
7.2.1 Europe Classical Swine Fever Vaccines Sales by Sales Channel (2017-2028)
7.2.2 Europe Classical Swine Fever Vaccines Revenue by Sales Channel (2017-2028)
7.3 Europe Classical Swine Fever Vaccines Market Size by Country
7.3.1 Europe Classical Swine Fever Vaccines Sales by Country (2017-2028)
7.3.2 Europe Classical Swine Fever Vaccines Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Classical Swine Fever Vaccines Market Size by Source
8.1.1 Asia Pacific Classical Swine Fever Vaccines Sales by Source (2017-2028)
8.1.2 Asia Pacific Classical Swine Fever Vaccines Revenue by Source (2017-2028)
8.2 Asia Pacific Classical Swine Fever Vaccines Market Size by Sales Channel
8.2.1 Asia Pacific Classical Swine Fever Vaccines Sales by Sales Channel (2017-2028)
8.2.2 Asia Pacific Classical Swine Fever Vaccines Revenue by Sales Channel (2017-2028)
8.3 Asia Pacific Classical Swine Fever Vaccines Market Size by Region
8.3.1 Asia Pacific Classical Swine Fever Vaccines Sales by Region (2017-2028)
8.3.2 Asia Pacific Classical Swine Fever Vaccines Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Classical Swine Fever Vaccines Market Size by Source
9.1.1 Latin America Classical Swine Fever Vaccines Sales by Source (2017-2028)
9.1.2 Latin America Classical Swine Fever Vaccines Revenue by Source (2017-2028)
9.2 Latin America Classical Swine Fever Vaccines Market Size by Sales Channel
9.2.1 Latin America Classical Swine Fever Vaccines Sales by Sales Channel (2017-2028)
9.2.2 Latin America Classical Swine Fever Vaccines Revenue by Sales Channel (2017-2028)
9.3 Latin America Classical Swine Fever Vaccines Market Size by Country
9.3.1 Latin America Classical Swine Fever Vaccines Sales by Country (2017-2028)
9.3.2 Latin America Classical Swine Fever Vaccines Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Classical Swine Fever Vaccines Market Size by Source
10.1.1 Middle East and Africa Classical Swine Fever Vaccines Sales by Source (2017-2028)
10.1.2 Middle East and Africa Classical Swine Fever Vaccines Revenue by Source (2017-2028)
10.2 Middle East and Africa Classical Swine Fever Vaccines Market Size by Sales Channel
10.2.1 Middle East and Africa Classical Swine Fever Vaccines Sales by Sales Channel (2017-2028)
10.2.2 Middle East and Africa Classical Swine Fever Vaccines Revenue by Sales Channel (2017-2028)
10.3 Middle East and Africa Classical Swine Fever Vaccines Market Size by Country
10.3.1 Middle East and Africa Classical Swine Fever Vaccines Sales by Country (2017-2028)
10.3.2 Middle East and Africa Classical Swine Fever Vaccines Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 WINSUN
11.1.1 WINSUN Corporation Information
11.1.2 WINSUN Overview
11.1.3 WINSUN Classical Swine Fever Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 WINSUN Classical Swine Fever Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 WINSUN Recent Developments
11.2 Merial
11.2.1 Merial Corporation Information
11.2.2 Merial Overview
11.2.3 Merial Classical Swine Fever Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Merial Classical Swine Fever Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Merial Recent Developments
11.3 CAHIC
11.3.1 CAHIC Corporation Information
11.3.2 CAHIC Overview
11.3.3 CAHIC Classical Swine Fever Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 CAHIC Classical Swine Fever Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 CAHIC Recent Developments
11.4 Chopper Biology
11.4.1 Chopper Biology Corporation Information
11.4.2 Chopper Biology Overview
11.4.3 Chopper Biology Classical Swine Fever Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Chopper Biology Classical Swine Fever Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Chopper Biology Recent Developments
11.5 MSD Animal Health (Merck)
11.5.1 MSD Animal Health (Merck) Corporation Information
11.5.2 MSD Animal Health (Merck) Overview
11.5.3 MSD Animal Health (Merck) Classical Swine Fever Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 MSD Animal Health (Merck) Classical Swine Fever Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 MSD Animal Health (Merck) Recent Developments
11.6 ChengDu Tecbond
11.6.1 ChengDu Tecbond Corporation Information
11.6.2 ChengDu Tecbond Overview
11.6.3 ChengDu Tecbond Classical Swine Fever Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 ChengDu Tecbond Classical Swine Fever Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 ChengDu Tecbond Recent Developments
11.7 Ceva
11.7.1 Ceva Corporation Information
11.7.2 Ceva Overview
11.7.3 Ceva Classical Swine Fever Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Ceva Classical Swine Fever Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Ceva Recent Developments
11.8 Harbin Veterinary Research Institute
11.8.1 Harbin Veterinary Research Institute Corporation Information
11.8.2 Harbin Veterinary Research Institute Overview
11.8.3 Harbin Veterinary Research Institute Classical Swine Fever Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Harbin Veterinary Research Institute Classical Swine Fever Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Harbin Veterinary Research Institute Recent Developments
11.9 Qilu Animal Health Products Factory
11.9.1 Qilu Animal Health Products Factory Corporation Information
11.9.2 Qilu Animal Health Products Factory Overview
11.9.3 Qilu Animal Health Products Factory Classical Swine Fever Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Qilu Animal Health Products Factory Classical Swine Fever Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Qilu Animal Health Products Factory Recent Developments
11.10 Ringpu Biology
11.10.1 Ringpu Biology Corporation Information
11.10.2 Ringpu Biology Overview
11.10.3 Ringpu Biology Classical Swine Fever Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Ringpu Biology Classical Swine Fever Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Ringpu Biology Recent Developments
11.11 DHN
11.11.1 DHN Corporation Information
11.11.2 DHN Overview
11.11.3 DHN Classical Swine Fever Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 DHN Classical Swine Fever Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 DHN Recent Developments
11.12 CAVAC
11.12.1 CAVAC Corporation Information
11.12.2 CAVAC Overview
11.12.3 CAVAC Classical Swine Fever Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 CAVAC Classical Swine Fever Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 CAVAC Recent Developments
11.13 Komipharm
11.13.1 Komipharm Corporation Information
11.13.2 Komipharm Overview
11.13.3 Komipharm Classical Swine Fever Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Komipharm Classical Swine Fever Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Komipharm Recent Developments
11.14 Agrovet
11.14.1 Agrovet Corporation Information
11.14.2 Agrovet Overview
11.14.3 Agrovet Classical Swine Fever Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Agrovet Classical Swine Fever Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Agrovet Recent Developments
11.15 Bioveta
11.15.1 Bioveta Corporation Information
11.15.2 Bioveta Overview
11.15.3 Bioveta Classical Swine Fever Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Bioveta Classical Swine Fever Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Bioveta Recent Developments
11.16 Jinyu Bio-Technology
11.16.1 Jinyu Bio-Technology Corporation Information
11.16.2 Jinyu Bio-Technology Overview
11.16.3 Jinyu Bio-Technology Classical Swine Fever Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Jinyu Bio-Technology Classical Swine Fever Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Jinyu Bio-Technology Recent Developments
11.17 Institutul Pasteur
11.17.1 Institutul Pasteur Corporation Information
11.17.2 Institutul Pasteur Overview
11.17.3 Institutul Pasteur Classical Swine Fever Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Institutul Pasteur Classical Swine Fever Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Institutul Pasteur Recent Developments
11.18 MVP
11.18.1 MVP Corporation Information
11.18.2 MVP Overview
11.18.3 MVP Classical Swine Fever Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 MVP Classical Swine Fever Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 MVP Recent Developments
11.19 Tecon
11.19.1 Tecon Corporation Information
11.19.2 Tecon Overview
11.19.3 Tecon Classical Swine Fever Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.19.4 Tecon Classical Swine Fever Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Tecon Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Classical Swine Fever Vaccines Industry Chain Analysis
12.2 Classical Swine Fever Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Classical Swine Fever Vaccines Production Mode & Process
12.4 Classical Swine Fever Vaccines Sales and Marketing
12.4.1 Classical Swine Fever Vaccines Sales Channels
12.4.2 Classical Swine Fever Vaccines Distributors
12.5 Classical Swine Fever Vaccines Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Classical Swine Fever Vaccines Industry Trends
13.2 Classical Swine Fever Vaccines Market Drivers
13.3 Classical Swine Fever Vaccines Market Challenges
13.4 Classical Swine Fever Vaccines Market Restraints
14 Key Findings in The Global Classical Swine Fever Vaccines Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer